We are live on ! Find out more
BWLSA

Blue Water Life Science Advisors Portfolio holdings

AUM $159M
1-Year Est. Return 139.66%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
AUM
$110M
AUM Growth
-$16.7M
Cap. Flow
-$22.6M
Cap. Flow %
-20.62%
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
Reduced
3
Closed
2

Top Buys

Rank Stock Value
1
TEM
Tempus AI
TEM
+$5.07M

Top Sells

Rank Stock Value
1
TXG icon
10x Genomics
TXG
+$12.7M
2
AKYA
Akoya BioSciences
AKYA
+$6.11M
3
NTRA icon
Natera
NTRA
+$3.96M
4
CDNA icon
CareDx
CDNA
+$3.05M
5
GH icon
Guardant Health
GH
+$1.82M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADPT icon
1
Adaptive Biotechnologies
ADPT
$4.07B
$32.1M 29.28%
2,145,145
GH icon
2
Guardant Health
GH
$21.9B
$25.3M 23.12%
405,647
-33,400
-8% -$1.82M
NTRA icon
3
Natera
NTRA
$46.9B
$22.8M 20.78%
141,494
-25,000
-15% -$3.96M
PSNL icon
4
Personalis
PSNL
$1.69B
$10.9M 9.97%
1,676,300
CDNA icon
5
CareDx
CDNA
$2.41B
$7.42M 6.77%
510,000
-214,014
-30% -$3.05M
TEM
6
Tempus AI
TEM
$11.1B
$5.84M 5.33%
+72,412
New +$5.07M
QTRX icon
7
Quanterix
QTRX
$140M
$5.2M 4.74%
957,747
AKYA
8
DELISTED
Akoya BioSciences
AKYA
-4,697,785
Closed -$6.11M
TXG icon
9
10x Genomics
TXG
$8.1B
-1,100,720
Closed -$12.7M

Similar funds

Blue Water Life Science Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Blue Water Life Science Advisors held 9 positions worth $110M, down 13% from $126M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Blue Water Life Science Advisors withdrew a net $22.6M in Q3 2025, closing 2 positions and reducing 3 holdings. Its most notable exit was 10x Genomics, an estimated $12.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Blue Water Life Science Advisors opened a new position in Tempus AI worth $5.84M.

  • Blue Water Life Science Advisors's largest Q3 2025 buy was Tempus AI: 72,412 shares worth $5.84M.
  • Blue Water Life Science Advisors's biggest Q3 2025 reduction was Natera, cutting an estimated $3.96M.
  • Blue Water Life Science Advisors fully exited 10x Genomics in Q3 2025, selling an estimated $12.7M.
  • Blue Water Life Science Advisors's ten largest holdings make up 100% of its $110M portfolio in Q3 2025.
  • Blue Water Life Science Advisors opened 1 new position and closed 2 in Q3 2025.
  • Blue Water Life Science Advisors's portfolio value fell 13% quarter-over-quarter to $110M.

Based on Blue Water Life Science Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.